Immunotherapy Updates in Advanced Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is the second most common cause of cancer death worldwide. HCC tumor development and treatment resistance are impacted by changes in the microenvironment of the hepatic immune system. Immunotherapy has the potential to improve response rates by overcoming immune tolera...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Cancers 2021-04, Vol.13 (9), p.2164
Hauptverfasser:	Singh, Amisha, Beechinor, Ryan J, Huynh, Jasmine C, Li, Daneng, Dayyani, Farshid, Valerin, Jennifer B, Hendifar, Andrew, Gong, Jun, Cho, May
Format:	Artikel
Sprache:	eng
Schlagworte:	Antigens Antitumor agents Apoptosis Bevacizumab Cell therapy Chimeric antigen receptors Clinical trials Cytokines Cytotoxicity FDA approval Hepatocellular carcinoma Immune checkpoint inhibitors Immune system Immunological tolerance Immunotherapy Kinases Liver cancer Lymphocytes Medical prognosis Monoclonal antibodies Pathogenesis Review Toxicity Tumor microenvironment Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!